A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Clinical trial NCT06065540 · COMPLETED
Trial details
- NCT number
- NCT06065540
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-27
- Primary completion
- 2025-11-19
- Enrollment
- 2734
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.